VEGF-A polymorphisms affect the pharmacologic effect of bevacizumab on VEGF-A levels in patients with metastatic colorectal cancer.

被引：0
|
作者：
Papachristos, Apostolos
Kemos, Polychronis
Kalofonos, Haralabos
Sivolapenko, Gregory
机构：
[1] Univ Patras, Sch Hlth Sci, Dept Pharm, Lab Pharmacokinet, Rion, Greece
[2] Queen Mary Univ London, Blizard Inst, London, England
[3] Univ Hosp Patras, Dept Internal Med, Div Oncol, Patras, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15505
引用
收藏
页数：1
相关论文
共 50 条
  • [21] VEGF-A levels in bevacizumab-treated breast cancer patients: a systematic review and meta-analysis
    dos Santos, Lucas Vieira
    Cruz, Marcelo Rocha
    Lopes, Gilberto de Lima
    da Silveira Nogueira Lima, Joao Paulo
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 481 - 489
  • [22] Combined perioperative plasma endoglin and VEGF-A assessment in colorectal cancer patients
    Mysliwiec, Piotr
    Pawlak, Krystyna
    Kuklinski, Adam
    Kedra, Boguslaw
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (02) : 231 - 236
  • [23] The expression and diagnostic value of serum levels of EphA2 and VEGF-A in patients with colorectal cancer
    Wang, Ganbiao
    Wang, Yigao
    Yang, Xiaodong
    Zhang, Yaqin
    Lu, Yida
    Li, Yongxiang
    CANCER BIOMARKERS, 2021, 31 (04) : 399 - 408
  • [24] VEGF-A and Cox-2 gene polymorphisms and susceptibility to colorectal cancer in Brazilian population
    Tomitao, Michele T. P.
    Kubrusly, Marcia S.
    Cotti, Guilherme C.
    Zaidan, Evelise P.
    Safatle-Ribeiro, Adriana V.
    Marie, Suely K. N.
    Cecconello, Ivan
    Nahas, Sergio C.
    Ribeiro, Ulysses
    CANCER RESEARCH, 2013, 73 (08)
  • [25] Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
    Pentheroudakis, George
    Kotoula, Vassiliki
    Kouvatseas, George
    Charalambous, Elpida
    Dionysopoulos, Dimitrios
    Zagouri, Flora
    Koutras, Angelos
    Papazisis, Konstantinos
    Pectasides, Dimitrios
    Samantas, Epaminontas
    Dimopoulos, Meletios A.
    Papandreou, Christos N.
    Fountzilas, George
    CLINICAL BREAST CANCER, 2014, 14 (05) : 330 - 338
  • [26] VEGF-A and ICAM-1 Gene Polymorphisms as Predictors of Clinical Outcome to First-Line Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
    Papachristos, Apostolos
    Kemos, Polychronis
    Katsila, Theodora
    Panoilia, Eirini
    Patrinos, George P.
    Kalofonos, Haralabos
    Sivolapenko, Gregory B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [27] The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer
    Inanc, Mevlude
    Sirakaya, Hatice Aslan
    Karaman, Hatice
    Bozkurt, Oktay
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (08) : 1878 - 1885
  • [28] Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC
    Kentaro Tanaka
    Jun Sugisaka
    Yoshimasa Shiraishi
    Yasutaka Watanabe
    Haruko Daga
    Koichi Azuma
    Kazumi Nishino
    Masahide Mori
    Takayo Ota
    Haruhiro Saito
    Akito Hata
    Tadashi Sakaguchi
    Toshiyuki Kozuki
    Hiroaki Akamatsu
    Hirotaka Matsumoto
    Motoko Tachihara
    Kazushige Wakuda
    Yuki Sato
    Tomohiro Ozaki
    Yuko Tsuchiya-Kawano
    Nobuyuki Yamamoto
    Kazuhiko Nakagawa
    Isamu Okamoto
    Nature Communications, 16 (1)
  • [29] Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities
    Tura, Ayseguel
    Pawlik, Vera E.
    Rudolf, Martin
    Ernesti, Justus S.
    Stutzer, Jan-Niklas
    Grisanti, Salvatore
    Ranjbar, Mandy
    CANCERS, 2019, 11 (06):
  • [30] Soluble VEGF-A and lymphangiogenesis in metastatic malignant melanoma patients.
    Soubrane, C.
    Mouawad, R.
    Sultan, V.
    Spano, J.
    Khayat, D.
    Rixe, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 465S - 465S
12345